Proton Beam Therapy for Untreated Hepatocellular Carcinoma Unsuitable for Transcatheter Arterial Chemoembolization
PBT for TACE-unsuitable previously untreated HCC, which can be a noninferior treatment option if the number of tumors is limited, but suppression of out-of-field recurrence is needed for further prolongation of survival.
Authors
- Takashi Iizumi (ORCID: https://orcid.org/0000-0001-6632-4356)
- Masashi Mizumoto (ORCID: https://orcid.org/0000-0001-7837-1301)
- Naoyuki Hasegawa (ORCID: https://orcid.org/0000-0002-1005-8498)
- Toshiyuki Okumura (ORCID: https://orcid.org/0000-0001-5742-8794)
- Takafumi Ikeda (ORCID: https://orcid.org/0000-0003-0299-1998)
- Hirokazu Makishima (ORCID: https://orcid.org/0000-0003-0380-0778)
- Kei Nakai (ORCID: https://orcid.org/0000-0002-0702-2304)
- Haruko Numajiri
- Hikaru Niitsu (ORCID: https://orcid.org/0000-0001-8127-254X)
- Takashi Saito (ORCID: https://orcid.org/0000-0002-2565-8795)
- Hideyuki Sakurai
Institutions
- University of Tsukuba (JP)
- National Institutes for Quantum Science and Technology (JP)
- Ibaraki Prefectural Central Hospital (JP)
Publication Details
- Journal
- Liver Cancer
- Published
- 2025-09-15
- DOI
- https://doi.org/10.1159/000548347
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.32